Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.
Gandemer V, Pochon C, Oger E, Dalle JH, Michel G, Schmitt C, de Berranger E, Galambrun C, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rorhlich P, Lutz P, Demeocq F, Schneider P, Plantaz D, Poirée M, Bordigoni P. Gandemer V, et al. Among authors: de berranger e. Br J Haematol. 2014 May;165(3):392-401. doi: 10.1111/bjh.12749. Epub 2014 Jan 30. Br J Haematol. 2014. PMID: 24479958 Free article. Clinical Trial.
New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning.
Poinsignon V, Faivre L, Nguyen L, Neven B, Broutin S, Moshous D, Bourget P, Dufour C, Dalle JH, Galambrun C, Devictor B, Kemmel V, De Berranger E, Gandemer V, Vannier JP, Jubert C, Bondu S, Mir O, Petain A, Vassal G, Paci A. Poinsignon V, et al. Among authors: de berranger e. Pediatr Blood Cancer. 2020 Oct;67(10):e28603. doi: 10.1002/pbc.28603. Epub 2020 Jul 24. Pediatr Blood Cancer. 2020. PMID: 32706505
Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
de Berranger E, Cousien A, Petit A, Peffault de Latour R, Galambrun C, Bertrand Y, Salmon A, Rialland F, Rohrlich PS, Vannier JP, Lutz P, Yakouben K, Duhamel A, Bruno B, Michel G, Dalle JH. de Berranger E, et al. Bone Marrow Transplant. 2014 Mar;49(3):382-8. doi: 10.1038/bmt.2013.185. Epub 2013 Dec 9. Bone Marrow Transplant. 2014. PMID: 24317131
[Preservation/congelation of hematopoietic stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J, de Berranger E, Jubert C, Pochon C, Letellier C, Mialou V, Sirvent A, Yakoub-Agha I, Dalle JH. De Vos J, et al. Among authors: de berranger e. Bull Cancer. 2017 Dec;104(12S):S136-S141. doi: 10.1016/j.bulcan.2017.04.008. Epub 2017 Nov 21. Bull Cancer. 2017. PMID: 29169651 Review. French.
Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Belaiche S, Décaudin B, Caron A, Depas N, Vignaux C, Vigouroux S, Coiteux V, Magro L, Sirvent A, Huynh A, Turlure P, Farge D, Lioure B, Bruno B, De Berranger E, Maillard N, Bourhis JH, Bay JO, Bulabois CE, Ceballos P, Fegueux N, Hicheri Y, Vincent L, Rialland F, Gandemer V, Taque S, Cornillon J, Contentin N, Galambrun C, Plantaz D, Odou P, Yakoub-Agha I. Belaiche S, et al. Among authors: de berranger e. Fundam Clin Pharmacol. 2021 Apr;35(2):435-445. doi: 10.1111/fcp.12593. Epub 2021 Jan 7. Fundam Clin Pharmacol. 2021. PMID: 32740936
[Post-hematopietic stem cell transplant complications].
de Berranger E, Jubert C, Michel G. de Berranger E, et al. Bull Cancer. 2015 Jul-Aug;102(7-8):648-55. doi: 10.1016/j.bulcan.2015.04.005. Epub 2015 May 8. Bull Cancer. 2015. PMID: 25962541 Review. French.
Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric Oncology.
Rouger-Gaudichon J, Thébault E, Félix A, Phulpin A, Paillard C, Alimi A, Brethon B, Gouache E, Raimbault S, de Berranger E, Poirée M, Bouttefroy S, André N, Gandemer V, On Behalf Of Société Française de Lutte Contre Les Cancers Et Leucémies de l'Enfant Et de L'adolescent Sfce. Rouger-Gaudichon J, et al. Among authors: de berranger e. Cancers (Basel). 2020 Nov 17;12(11):3398. doi: 10.3390/cancers12113398. Cancers (Basel). 2020. PMID: 33212828 Free PMC article.
Impact of COVID-19 on cancer care: A survey from the French Society of Pediatric Oncology (SFCE).
Rouger-Gaudichon J, Gariazzo L, Thébault E, Brethon B, Fenwarth L, Gambart M, Alimi A, Réguerre Y, Piguet C, Jubert C, Gouache E, Thébaud E, Plantaz D, Paillard C, Raimbault S, Haouy S, Schneider P, Phulpin A, Mallebranche C, Dubrasquet M, de Berranger E, Devoldere C, Laithier V, Poirée M, Thouvenin S, Carausu L, Dupraz C, Bouttefroy S, André N, Gandemer V. Rouger-Gaudichon J, et al. Among authors: de berranger e. Pediatr Blood Cancer. 2021 Jan;68(1):e28554. doi: 10.1002/pbc.28554. Epub 2020 Sep 7. Pediatr Blood Cancer. 2021. PMID: 32893961 No abstract available.
33 results